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Abstract Discrepancies between informants’ reports of child-
ren’s behavior are robustly observed in clinical child research
and have important implications for interpreting the outcomes
of controlled treatment trials. However, little is known about
the basic psychometric properties of these discrepancies. This
study examined the relation between parent-child reporting
discrepancies on measures of child social phobia symptoms,
administered before and after treatment for social phobia.
Participants included a clinic sample of 81 children (7–16 years
old [M=11.75, SD=2.57]; 39 girls, 42 boys) and their parents
receiving treatment as part of a multisite controlled trial.
Pretreatment parent-child reporting discrepancies predicted
parent-child discrepancies at posttreatment, and these relations
were not better accounted for by the severity of the child’s
pretreatment primary diagnosis. Further, treatment responder
status moderated this relation: Significant relations were
identified for treatment non-responders and not for treatment
responders. Overall, findings suggest that informant discrep-
ancies can be reliably employed to measure individual differ-
ences over the course of controlled treatment trials. These data
provide additional empirical support for recent work suggest-
ing that informant discrepancies can meaningfully inform
understanding of treatment response as well as variability in
treatment outcomes.
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The absence of definitive measures for assessing clinical
conditions (e.g., anxiety, depression, disruptive behavior) in
children and adolescents (hereafter referred to collectively
as “children”) makes it critical to assess these conditions
from the perspectives of multiple informants (e.g., self,
significant other, clinician, laboratory observer, biological
indices). However, multiple clinical reports of a single child
are often in disagreement, both in terms of the level or
severity of symptoms and whether a child meets diagnostic
criteria (De Los Reyes and Kazdin 2005). These disagree-
ments (hereafter referred to as “informant discrepancies”)
are some of the most consistent effects observed in the
clinical child literature (Achenbach 2006).
Informant discrepancies are critical to understand for
numerous reasons. First, they commonly occur across
measurement methods (De Los Reyes and Kazdin 2005)
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and areas of the clinical sciences (e.g., Achenbach et al.
1987; Clancy et al. 2005; De Los Reyes and Prinstein 2004),
suggesting that the phenomenon is of general concern to
researchers interested in studying children’s behavior. Fur-
ther, prior work suggests that differences in the magnitudes
of informant discrepancies are dependent upon the problem
type (e.g., internalizing versus externalizing concerns) as
well as the informant pair (e.g., parent-child, mother-father,
parent-teacher) (Achenbach 2006). However, most discrep-
ancies typically fall in the moderate-to-large range (De Los
Reyes and Kazdin 2005). Second, informant discrepancies
frequently translate into inconsistent outcomes within con-
trolled treatment trials (e.g., De Los Reyes and Kazdin 2008;
Weisz et al. 2006; Weisz et al. 1987), making it difficult to
definitively determine treatment efficacy. Third, discrepan-
cies may indicate the development of poor child and family
psychosocial outcomes. For instance, when a parent and child
disagree in their reports of important behaviors (e.g., the
child’s behavior and emotional problems, parenting styles,
and parent-child relationship quality), these disagreements
predict negative outcomes including poorer treatment re-
sponse, poor parental participation in the child’s therapy, and
increases in the child’s behavioral and emotional problems
(Ferdinand et al. 2004; Guion et al. 2009; Israel et al. 2007;
Panichelli-Mindel et al. 2005; Pelton and Forehand 2001;
Pelton et al. 2001). In short, informant discrepancies occur
often and have numerous implications for the assessment,
development, and treatment of child psychopathology.
Recently, researchers have focused on whether informant
discrepancies may aid in understanding the outcomes of
controlled treatment trials (De Los Reyes and Kazdin
2006a, 2009; Koenig et al. 2009). Indeed, when outcome
reports are inconsistent, one might initially question
whether treatment yielded positive outcomes and/or wheth-
er some of the informants’ reports were unreliable.
Alternatively, discrepancies might reveal the circumstances
in which a treatment is effective (i.e., mediators and
moderators of outcome). For example, parent reports might
suggest that the treatment was effective whereas teacher
reports might suggest a lack of improvement. These
differential outcomes might indicate that: (a) the interven-
tion significantly reduced problematic behaviors expressed
in the home (e.g., negative interactions with siblings) but
not in non-home settings; and/or (b) significant changes in
behavior occurred at school but teacher reports were
unreliable or did not accurately represent these changes.
Interestingly, examining whether discrepancies yield mean-
ingful information is a testable question rarely addressed
in the clinical literature. Yet, examining these issues may
yield knowledge on how outcomes vary for different
children.
Recent research highlights the utility of informant
discrepancies for informing controlled trials research. First,
meta-analytic evidence suggests that the multiple outcome
measures commonly used to test treatment efficacy can be
examined to identify patterns of consistent and inconsistent
treatment effects (De Los Reyes and Kazdin 2009). For
example, behavioral parent training interventions developed
to treat childhood disruptive behavior commonly use
outcomes measures administered to parents, teachers, and
laboratory observers. Yet, robust informant-specific effects
(i.e., multiple measures completed by the same informant
suggesting positive treatment outcomes) are most often
observed via parent-reported outcomes (De Los Reyes and
Kazdin 2009). On the surface, such findings might suggest
that reports provided by informants other than parents are
unreliable or that treatment was ineffective because parent
reports were not corroborated by other informants’ reports.
However, recent work calls these interpretations into
question. For instance, parent-teacher discrepancies in
reports of preschoolers’ disruptive behavior symptoms
predict laboratory observations of the interactions in which
these same preschoolers exhibit disruptive behavior (De
Los Reyes et al. 2009a). Specifically: (a) parent reports
(and not teacher reports) predict observed disruptive
behavior within parent-child interactions; (b) teacher
reports (and not parent reports) predict observed disruptive
behavior within interactions between the child and a non-
parental adult (clinical examiner); and (c) when combined,
parent and teacher reports predict disruptive behavior that is
observed across adult-child interactions. Taken together,
these findings suggest a systematic nature to informant
discrepancies; so much so that within controlled treatment
trials, discrepancies may reveal where (e.g., home, school)
a treatment changed children’s behavior.
Informant discrepancies may contain meaningful infor-
mation, leading to hypotheses as to how and why treat-
ments change behavior within controlled trials. However,
the field has a poor understanding of the psychometric
properties of informant discrepancies. It remains unclear
whether measures of discrepancies have the same psycho-
metric properties as reliable and valid assessment measures.
For instance, do repeated measurements of informant discrep-
ancies relate to each other, such that informant discrepancies
observed at one time point (e.g., prior to treatment) predict
discrepancies at other time points (e.g., once treatment is
complete)? Indeed, understanding the stability of informant
discrepancies is necessary to clarify treatment response;
understanding this stability would allow researchers to predict
the presence of informant discrepancies at multiple points
(e.g., baseline, posttreatment, follow-up).
Prior theoretical work suggests that informant discrepan-
cies may indeed exhibit stable measurement properties. The
Attribution Bias Context Model (De Los Reyes and Kazdin
2005) is a multidisciplinary framework that attempts to
explain why informant discrepancies exist in clinical child
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assessments. The framework builds on basic research and
theory on memory and interpersonal perception as well as
multi-informant clinical assessment (Achenbach 2006;
Johnson et al. 1993; Jones and Nisbett 1972; Malle 2006;
Mash and Terdal 1988; Pasupathi 2001). Briefly, the
framework posits that discrepant reports of a given behavior
exist because informants differ on three critical character-
istics: (a) what they attribute to be the causes of the behavior
(i.e., dispositional qualities of the child versus environmental
constraints); (b) the perspectives by which they perceive
whether or which behaviors warrant treatment; and (c) the
contexts within which they observe the behavior. Thus,
informant discrepancies occur because of systematic differ-
ences between informants’ experiences with and perceptions
of the behavior being assessed. As such, these systematic
differences should translate into predictable differences
between informants’ reports over multiple assessments.
The basic tenets of the Attribution Bias Context
Model have empirical support. For example, as men-
tioned previously informant discrepancies may be useful
markers of the variable expression of children’s behavior
across settings (De Los Reyes et al. 2009a). However,
whether informant discrepancies reflect systematic varia-
tions between informants’ reports over time has not been
empirically tested. Therefore, the present study examines
whether informant discrepancies assessed before children’s
treatments predict such discrepancies after treatment is
complete, using a sample of children treated for social phobia.
There are four key reasons for why informant discrepancies
are crucial to study within controlled trials testing treatments,
including childhood social phobia. First, observed high rates
of reporting disagreements within clinic samples of anxious
children are commonly reported (Choudhury et al. 2003;
Grills and Ollendick 2003; Rapee et al. 1994). Second,
controlled treatment trials for childhood anxiety commonly
use outcome measures from multiple informants (e.g., Beidel
et al. 2007; Kendall 1994; Silverman et al., 1999a, b; Weisz
et al. 2005). Third, informant disagreements occur at
pretreatment, posttreatment, and longitudinal follow-up
(Safford et al. 2005). This suggests that variability exists
between informants’ reports across multiple time points.
Thus, there is potential for pretreatment discrepancies to
predict discrepancies over time.
Fourth and most critically, recent work suggests that
systematic patterns exist in parental and child reports of clinic
referred children’s anxiety symptoms. Specifically, when
parents and children endorse symptoms during structured
diagnostic interviews, disagreements tend to be lower when
the symptoms assessed are observable (e.g., behavioral
avoidance) and based on behaviors exhibited in non-school
settings. In contrast, higher disagreements occur when the
symptoms assessed are unobservable or subjectively
expressed (e.g., anxious worry) and based on behaviors
exhibited in school settings (Comer and Kendall 2004). Thus,
akin to parent and teacher reports of disruptive behavior (De
Los Reyes et al. 2009a), parent and child reports of anxiety
symptoms vary systematically in terms of the nature and
setting of the child’s symptoms. However, studies of
measurements of informant discrepancies and whether they
systematically relate to each other are lacking in empirical
work on clinically anxious children.
Conceivably, several factors may moderate the rela-
tion between discrepancies measurements. One factor
particularly relevant to controlled trials is the child’s
treatment response. Specifically, independent observers
(e.g., clinician, laboratory observer) often determine
whether a child experiences positive treatment response
based on interviews with other informants (e.g., parent,
child, and/or teacher; Guy 1976; Shaffer et al. 1983;
Silverman and Albano 1996). If identified as a treatment
responder, this might signify that informants agreed that
the treatment improved the child’s functioning. This is
the independent evaluator’s judgment, which relies on
information from informants. Thus, one might assume
that all informants provided consistent perceptions of
improvement. Yet, consistent perceptions of improvement
at posttreatment may prevent informant discrepancies
from demonstrating stability over the course of treatment.
This is because at the end of treatment, all informants
likely see the child’s response to treatment in much the
same way.
Conversely, when a child is not identified as a treatment
responder, informants may disagree that the child responded
to treatment. As a result, the informant discrepancies
observed at posttreatment for non-responding children
likely resemble the informant discrepancies observed at
pretreatment. Because informant discrepancies are consis-
tently observed in the absence of treatment (De Los Reyes
and Kazdin 2005), treatment non-response may reveal the
considerable predictive utility of pretreatment informant
discrepancies. Thus, a second aim of the present study is to
examine whether the predictive utility of pretreatment parent-
child reporting discrepancies is moderated bywhether the child
is identified by an independent evaluator as responding
positively to treatment.
This study examined whether pretreatment informant
discrepancies in reports of child social phobia predict
posttreatment informant discrepancies. We addressed this
question using data from a multisite controlled clinical
trial of psychological and pharmacological treatments for
childhood social phobia (Beidel et al. 2007). On the
assumption that we would identify the low-to-moderate
levels of agreement commonly observed in prior work (De
Los Reyes and Kazdin 2005), we predicted that pretreat-
ment parent-child reporting discrepancies would predict
posttreatment discrepancies. We expected that this rela-
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tionship would be robust to taking into account pretreat-
ment diagnostic severity. This is important because
clinicians often rely on parent and child reports to
determine a child’s baseline level of functioning (Hawley
and Weisz 2003). Additionally, we expected that the
relation between pretreatment and posttreatment informant
discrepancies would be moderated by child responder
status at posttreatment. That is, a predictive effect would




Participants included 81 parent-child (7–16 years old [M=
11.75, SD=2.57]; 39 girls, 42 boys) dyads for which the
child was receiving treatment as part of a multisite
controlled trial comparing pharmacological (fluoxetine)
and behavioral (Social Effectiveness Therapy for Children
[SET-C]; Beidel et al. 2000) treatments for social phobia
(see Beidel et al. 2007). Recruitment occurred through
media announcements (newspaper, radio) or through refer-
rals from local mental health professionals. All children met
criteria for a primary diagnosis of social phobia, generalized
subtype (American Psychiatric Association 2000) based on
child and parent semi-structured diagnostic interviews
(Anxiety Disorders Interview Schedule for Children
[ADIS-C/P]; Silverman and Albano 1996). In the case of
parent-child reporting discrepancies, clinicians arrived at a
diagnosis through composite diagnostic procedures for
integrating parent and child reports as outlined by Silverman
and Albano (1996).
To be included in the controlled trial, youths had to have a
primary diagnosis of social phobia. To be considered primary,
social phobia symptoms were of at least moderate severity (4
or higher on an 8-point scale) and created functional
impairment. Coexisting disorders could not have higher
severity ratings or cause more substantial impairment. To
ensure generalization of study findings, secondary comorbid
diagnoses were allowed, with the exception of bipolar
disorder, psychosis, conduct disorder, autism spectrum dis-
orders, and mental retardation. Youth with moderate to severe
depression who expressed active suicidal ideation or who
had a previous unsuccessful trial of fluoxetine or behavior
therapy were excluded. In the present sample, parents and
children were included if they provided complete ques-
tionnaire information on the child’s social phobia symp-
toms at pretreatment and immediately posttreatment.
Thus, this sample was culled from a larger sample of
139 dyads. Detailed information on demographic and
clinical characteristics for the total sample has been
reported elsewhere (Beidel et al. 2007).1
Measures
Social phobia symptoms Both parents and children com-
pleted respective versions of the Social Phobia and
Anxiety Inventory for Children (SPAIC; Beidel et al.
1995) at pre- and posttreatment. The scale consists of 26
items that assess the range of situations known to be
anxiety provoking to children with social phobia. We used
the SPAIC total score for which acceptable levels of
internal consistency and test-retest reliability have been
reported and for which well established psychometric
properties for assessing clinically relevant social phobia in
children are available (Silverman and Ollendick 2005). At
pretreatment, Cronbach’s alpha coefficients for this sam-
ple were 0.95 for the parent-report items and 0.97 for the
child-report items (alpha analyses based on complete item
data for 77 parents and 79 children). At posttreatment,
Cronbach’s alpha coefficients for this sample were 0.96
for the parent-report items and 0.97 for the child-report
items (alpha analyses based on complete item data for 75
parents and 78 children).
Reporting discrepancies on childhood social phobia
symptoms Parent-child reporting discrepancies were assessed
using standardized difference scores (SDS), consistent with
current recommendations and practices (e.g., De Los Reyes et
al. 2008; De Los Reyes and Kazdin 2004, 2006b; Guion et
al. 2009; Owens et al. 2007; Weems et al. 2007; Weems
et al., in press). Standardized difference scores were created
by first converting each SPAIC total score into a z score and
then subtracting the child’s SPAIC z score from the parent’s
SPAIC z score (hereby referred to as SPAIC-Standardized
Difference Scores [SPAIC-SDS]). Alternative measurements
of informant discrepancies have been proposed and used in
prior work, such as raw difference scores (i.e., use of
1 We conducted exploratory analyses to examine whether the 81
parents and children examined in this study differed from the rest of
the sample at pretreatment as a function of demographic (e.g., child
age, gender, ethnicity, socioeconomic status), pretreatment functioning
(e.g., primary diagnosis type, clinical severity of primary diagnosis,
broadband internalizing and externalizing problems [Child Behavior
Checklist; Achenbach 1991], SPAIC scores), or treatment character-
istics (e.g., treatment condition, treatment site). We conducted a large
number of tests (n=13) and did not have a priori hypotheses to
advance. Thus, we set a pre-defined bonferroni-corrected p-value
threshold for these tests of 0.004 (i.e., .05/13). Across these 13 tests,
none of these factors evidenced a significant relation to inclusion/
exclusion into this study.
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unstandardized rather than standardized scores) and residual
difference scores (i.e., measurements of the unshared
variance between two informants’ scores). However, stan-
dardized difference scores are a better representation of
informant discrepancies, because reports from which dis-
crepancies scores are created often correlate too highly with
raw difference and residual difference scores (see De Los
Reyes and Kazdin 2004). That is, raw difference and residual
difference scores are often statistically redundant with the
informants’ ratings used to compute the scores. Further
discussions of the mathematical properties of SDS can be
found elsewhere (De Los Reyes and Kazdin 2004; Guion et
al. 2009; Owens et al. 2007).
Clinical severity of primary diagnosis Interviews of the
parent and child were conducted using the ADIS-C/P
(Silverman and Albano 1996). Interviewers assigned a
clinical severity rating for each disorder present using the 8-
point Clinical Severity Rating Scale (ADIS-C/P CSR). For
the total sample, 20% of the interviews were audiotaped
and scored by a second interviewer (10% of the tapes from
one site were sent to the other site to ensure intersite
reliability). For the total sample, we observed strong
interrater reliability for a social phobia diagnosis (kappa=
0.78). Other diagnoses were not diagnosed with sufficient
frequency to allow ratings of interrater agreement. For the
total sample, interrater reliability for the social phobia CSR
was r=0.82.
Treatment responder status Treatment responder status was
assessed using the Clinical Global Impressions (CGI)
Severity of Illness and Improvement Scale (Guy 1976).
The CGI was completed by the pretreatment diagnostic
interviewer and by a posttreatment independent evaluator
blinded to group status (12 weeks). The interrater reliability
for the CGI, conducted for 20% of the total sample, was
r=0.86. A priori and consistent with other pharmacological
trials (Birmaher et al. 2003; Wagner et al. 2004), ratings of
1 (very much improved) or 2 (much improved) on the CGI
denoted a treatment responder, with ratings based on the
evaluator’s separate interviews with parent and child. Thus,
treatment responder status was dummy-coded “0” (not a
treatment responder) or “1” (treatment responder) (see
Table 1 for percentages).
Procedure
Parents contacted the clinic in response to study advertise-
ments or referrals from mental health professionals. Parents
received a scripted explanation of the study and participated in
a telephone interview, conducted by doctoral level graduate
students or trained staff members. The telephone interview
was used to screen for symptoms of social phobia and other
Axis I disorders, as well as the child’s psychological and
medical history. If the child met the basic eligibility require-
ments, the family was invited to the clinic to complete the
ADIS-C/P and a battery of questionnaires.
During the initial study visit, parent and child partici-
pated in a diagnostic interview conducted by a psychiatrist,
clinical psychologist, or doctoral student in clinical psy-
chology using the ADIS-C/P (Silverman and Albano 1996).
Parents were interviewed first, then the same clinician
interviewed the child. Diagnoses were based on information
provided by both informants. In the case of parent-child
disagreements, the final diagnosis was derived using
composite diagnostic procedures for integrating parent and
child reports as outlined by Silverman and Albano (1996).
The diagnostic interview was repeated at posttreatment
using the same procedure. Further information on study
procedures, treatments, and inclusion criteria have been
reported elsewhere (Beidel et al. 2007).
Results
Preliminary Analyses
Frequency distributions examined for all variables did not
reveal any deviations from normality. Correlations computed
between child and parent total SPAIC scores at pretreatment
(r=0.49, p<001) and posttreatment (r=0.30, p<0.01)
revealed significant but low-to-moderate correspondence
between parent and child ratings, consistent with previous
investigations (Achenbach 2006; De Los Reyes and Kazdin
2005).2
Means, standard deviations, and correlations among
measures Means and standard deviations (and proportions
for treatment responder status) for the measures completed
2 We conducted exploratory analyses to examine whether measures of
parent-child reporting discrepancies at either pre- or posttreatment
varied as a function of demographic (e.g., child age, gender, ethnicity,
socioeconomic status), pretreatment functioning (e.g., primary diag-
nosis type, clinical severity of primary diagnosis, broadband internal-
izing and externalizing problems [Child Behavior Checklist;
Achenbach 1991]), or treatment characteristics (e.g., treatment
condition, treatment site, treatment attrition, treatment response
status). We conducted a large number of tests (n=30) and did not
have a priori hypotheses to advance. Thus, we set a pre-defined
bonferroni-corrected p-value threshold of 0.001 (i.e., .05/30). Across
these 30 tests, none of these factors had a significant relationship to either
pre- or posttreatment reporting discrepancies.
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by parent, child, and clinician are presented in Table 1.
Correlations were calculated between continuous variables
used in the main tests of our hypotheses and SPAIC-SDS
(see Table 2). We identified significant bivariate relations
between pre- and posttreatment SPAIC-SDS. However,
SPAIC-SDS were not related to pretreatment ADIS-C/P
CSR. This is consistent with prior work suggesting that
informant discrepancies are not related to clinical impair-
ment (De Los Reyes et al. 2009a; De Los Reyes et al.
2009b). Nevertheless, we controlled for pretreatment CSR
in regression analyses in order to provide more conserva-
tive tests of our hypotheses.
Pre-Treatment Parent-Child Discrepancies
among Treatment Responders and Non-Responders
To first examine whether the two treatment response groups
differed in terms of pretreatment parent-child discrepancies,
we compared treatment responders and non-responders via
t-test group comparisons on pretreatment SPAIC-SDS. We
identified non-significant differences between treatment
non-responders, n=55; M=−0.08; SD=0.98, and treatment
responders, n=26; M=0.18; SD=1.06, on pretreatment
SPAIC-SDS, t=−1.11, ns. This suggests that the predictive
findings we report below are not simply due to pretreatment
differences between treatment responders and non-
responders on parent-child reporting discrepancies.
Predicting Posttreatment Parent-Child Discrepancies
from Pretreatment Discrepancies
To examine whether pretreatment parent-child discrepan-
cies of social phobia symptoms predict posttreatment
parent-child discrepancies after controlling for pretreatment
clinical severity, we conducted a hierarchical regression
analysis with posttreatment SPAIC-SDS serving as the
criterion variable. We entered pretreatment ADIS-C/P CSR
(continuous) in the first step as an independent variable. In
the second step, we entered as independent variables
pretreatment SPAIC-SDS (continuous), treatment responder
status (dichotomous), and the interaction term for these two
variables. In the presence of a significant interaction effect,
we used Holmbeck’s (2002) guidelines for post-hoc
probing of significant moderator effects. This included: (a)
computation of slope estimates using centered variables
(reducing multicollinearity) and (b) examining the statisti-
cal significance of these slopes for each level of treatment
responder status (i.e., the moderator variable). Results are
presented in Table 3.
Main regression model Results were consistent with our
hypotheses (Table 3). Specifically, in the first step of the
equation pretreatment ADIS-C/P CSR were not significant-
ly related to posttreatment SPAIC-SDS. In the second step,
the addition of pretreatment SPAIC-SDS, treatment re-
sponder status, and their interaction contributed significant
variance to the regression model. Specifically, after con-
trolling for pretreatment ADIS-C/P CSR, pretreatment
SPAIC-SDS significantly predicted posttreatment SPAIC-
SDS. Although treatment responder status did not indepen-
dently account for significant variance in the model, the
interaction between pretreatment SPAIC-SDS and treatment
responder status predicted posttreatment SPAIC-SDS.
Post-hoc probing of significant interaction Results of post-
hoc tests revealed a positive, significant slope between pre-
and posttreatment SPAIC-SDS for treatment non-responders.
Specifically, for non-responders greater levels of pretreatment
SPAIC-SDS predicted greater levels of posttreatment SPAIC-
SDS. The magnitude of this finding approached a large effect
Measure Parent Child Clinician
M (SD) M (SD) M (SD)
1. SPAIC Total Score
a. Pretreatment 34.57 (8.50) 27.75 (8.89)
b. Posttreatment 24.69 (10.43) 16.49 (10.84)
ADIS-C/P Primary Diagnosis CSR,
Pretreatment 5.98 (1.00)
Treatment Responder Status (%) 32
Table 1 Means (M) and
Standard Deviations (SD) of
Measures for the Total
Sample (N=81)
SPAIC Social Phobia and
Anxiety Inventory for Children;
ADIS-C/P Anxiety Disorders
Interview Schedule for Children;
CSR Clinician Severity Rating
Table 2 Correlations among Pre- and Posttreatment Parent-Child
Reporting Discrepancies (i.e., Standardized Difference Scores) on
Social Phobia Symptoms and Pretreatment Clinical Severity for the
Total Sample (N=81)
Variable 1 2 3
1. SPAIC-SDS, Pretreatment 0.24* −0.01
2. SPAIC-SDS, Posttreatment −0.19
3. ADIS-C/P CSR, Pretreatment
SPAIC Social Phobia and Anxiety Inventory for Children; SDS
Standardized Difference Score; ADIS-C/P Anxiety Disorders Inter-
view Schedule for Children; CSR Clinician Severity Rating; * p<0.05
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(r=0.50) as delineated by Cohen’s (1988) effect size
conventions, β=0.47; t=3.63, p<0.01. By comparison, we




Despite consistently high rates of informant discrepancies
in clinical child assessments, little is known about the
stability and utility of these commonly observed phenom-
ena, particularly within controlled trials research. This
study sheds significant light on the issue of informant
discrepancies and the interpretation of treatment outcome
data. Within a multisite controlled treatment trial for
childhood social phobia, we found that initial parent-child
reporting discrepancies predicted discrepancies over time,
and this prediction was sufficiently robust to account for the
severity of pretreatment primary diagnosis. Further, this
prediction was moderated by treatment response. Specifi-
cally, we found a significant and large predictive effect of
pretreatment discrepancies on posttreatment discrepancies
and only for children identified as treatment non-
responders. This finding is particularly interesting in light
of the fact that treatment responders and non-responders did
not significantly differ in their degree of pretreatment
parent-child reporting discrepancies.
The findings highlight the systematic nature of informant
discrepancies. We identified predictive effects where one
might expect to find differences between parent and child
perceptions of treatment outcome. Indeed, in this study an
independent evaluator blind to treatment condition inter-
viewed the parent and child (separately) in order to assess
the child’s improvement at posttreatment. As such, when
independent evaluators identified treatment non-responders,
this might characterize parents and children who discrep-
antly viewed improvements in the child’s functioning.
Thus, one would expect pretreatment discrepancies to
predict posttreatment discrepancies, because treatment
likely did not change parent and child views of behavior
and the child’s improvement over the course of treatment.
That is, parent and child were quite likely to discrepantly
perceive the child’s problems at outcome in much the same
way as they discrepantly perceived the child’s problems
before treatment began.
In contrast, when independent evaluators identified
treatment responders, this might characterize circumstances
where parents and children were likely to agree that
treatment improved the child’s functioning. For children
identified as treatment responders, this likely was in stark
contrast to how parents and children viewed the child’s
functioning before treatment began. In fact, numerous
studies suggest that in the absence of treatment, parent
and child often disagree on the nature and extent of the
child’s problems (Achenbach 2006). Here, the ability of
pretreatment informant discrepancies to predict posttreat-
ment discrepancies would not be expected, because parent
and child likely largely perceived the child’s target
problems discrepantly at baseline but largely agreed in
their perceptions of the child’s target problems at treatment
Table 3 Hierarchical Regression Analyses Examining Pretreatment Parent-Child Reporting Discrepancies (i.e., Standardized Difference Scores)
on Social Phobia Symptoms, Treatment Responder Status, and Their Interaction in Predicting Posttreatment Parent-Child Reporting Discrepancies
on Social Phobia Symptoms
Variable Main regression model Variable Post-Hoc tests of moderation
∆R2 B SeB β ∆R2 B SeB β
Step 1 0.03 Step 2 (When No Response=0) 0.15*
ADIS-C/P CSR, Pretreatment −0.21 0.12 −0.18 SPAIC-SDS 0.54 0.15 0.47*
Treatment Responder Status −0.25 0.26 −0.10
SDS X Responder Interaction −0.70 0.25 −0.35*
Step 2 0.15* Step 2 (When Response=0) 0.15*
SPAIC-SDS 0.54 0.15 0.47* SPAIC-SDS −0.15 0.20 −0.13
Treatment Responder Status −0.25 0.26 −0.10 Treatment Responder Status −0.25 0.26 −0.10
SDS X Responder Interaction −0.70 0.25 −0.35* SDS X Responder Interaction −0.70 0.25 −0.48*
For the main regression model (left side of table), Treatment Responder Status is coded “0” for No Response and “1” for Response; regression
terms for variables entered at Steps 1 and 2 are displayed, based on terms observed for these variables in Step 2 of the model; ∆R2 statistics for
each step were based on variables entered in that step; for the post-hoc moderation tests (right side of table), only Step 2 is reported (pretreatment
clinical severity was again a non-significant predictor in the first step), with the moderator variable Treatment Responder Status manipulated to
reflect when the absence of treatment response is coded 0 (“When No Response=0”), and when treatment response is coded 0 (“When Response =
0”) (see Holmbeck 2002); SPAIC Social Phobia and Anxiety Inventory for Children; SDS Standardized Difference Score; ADIS-C/P Anxiety
Disorders Interview Schedule for Children; CSR Clinician Severity Rating; * p<0.01
3 ierarchical Regre sion Analyses Exam ing P treatment
Parent-Child Reporting Discrep ncies (i.e., Standardized Difference
Scores) on S cial Phobia Symptoms, Treatment Responder Status, and
Their Int raction in Predicting Posttreatment Parent-Child Reporting
Discrepancies o Social Phobia Symp oms
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outcome. Stated another way, unlike treatment non-
responders, treatment responders were characterized by
significant improvements at post-treatment compared to
their functioning at baseline. This change likely prevented
parent-child discrepancies from demonstrating stability over
the course of treatment. Therefore, the findings suggest that
systematic and conceptually meaningful relations exist
between pre- and posttreatment informant discrepancies
and the extent of the child’s response to treatment.
Limitations
There are limitations to the present study. First, informant
discrepancies were assessed using standardized difference
scores. Some researchers have raised concerns about the
reliability of difference scores for assessing constructs such
as informant discrepancies and general variations between
scores (e.g., De Los Reyes and Kazdin 2004; Nunnally and
Bernstein 1994; Rogosa et al. 1982; Rogosa and Willett
1983). However, prior work has noted that when differ-
ences between informants’ reports exist, difference scores
demonstrate acceptable levels of reliability (Rogosa et al.
1982; Rogosa and Willett 1983). In any event, future
research should use different approaches to assess discrep-
ancies (e.g., direct assessments of perceived discrepancies).
Second, we did not assess parent and child perceptions
of treatment response independently of independent evalu-
ator ratings. As such, we were unable to test for differences
between independent evaluator-identified treatment res-
ponders and non-responders and parent and child percep-
tions of posttreatment change. We encourage future
research to replicate and extend our findings using multiple
informants’ reports of treatment response.
Third, we did not account for other factors that might
have reduced the stability between pre- and posttreatment
discrepancies. For example, we did not assess the degree to
which parent and child reports focused on the same social
phobia problems and behaviors at pre- and posttreatment
(i.e., response shift bias; see Kazdin 2003). For instance,
some children’s reports may have been more focused on
behaviors/concerns in one domain/setting before treatment
but “switched” in focus by posttreatment (e.g., school
anxiety at pretreatment but sports-related anxiety at
posttreatment). If parents and children (a) do not evidence
the same kind of response shift or (b) are discordant in
whether they engaged in response shift, this may promote
instability in discrepant reports over time. Thus, it may be
that our findings underestimate the stability of informant
discrepancies within controlled trials. These issues can be
addressed in future research. For instance, after completing
their pretreatment reports, researchers may solicit informa-
tion from informants on the behaviors (behavioral avoid-
ance, physiological arousal) or circumstances (home, school)
upon which they tended to base their reports. At the end of
treatment, informants can be randomly assigned to either
complete the measures in their standard format or receive
instructions on how to base their reports on the same
behaviors or circumstances upon which they based their
pretreatment reports. In any event, future research ought to
examine whether correcting for response shift increases the
predictive utility of pretreatment informant discrepancies.
Lastly, parent-child discrepancies were assessed with the
same measures at pre- and posttreatment. In many respects
this is a necessary criterion for conducting research on
informant discrepancies in that it ensures that assessments
are not confounded by differences in item content across
reports (see De Los Reyes and Kazdin 2004; Treutler and
Epkins 2003). At the same time, this may have inflated the
obtained relationships. Shared method variance due to the
common assessment formats and informants could have
increased correlations among measures. Of course, this
would happen for control variables (e.g., clinical severity
ratings, which are based on clinician, parent, and child
report), independent variables (e.g., pretreatment discrep-
ancy scores, treatment responder status, the interaction
between these two variables), and dependent variables (e.g.,
posttreatment discrepancy scores). That is, common method
variance could increase the likelihood that non-significant
findings would emerge, because the grand majority of study
variables were derived from highly similar methods, and
variables were often derived from information derived from
the same informants. Nevertheless, future research should
consider additional measures, including ratings from other
informants (e.g., fathers, teachers) and measures in the
home or other settings (e.g., school) that do not rely on the
same informants’ reports.
Research and Clinical Implications
As mentioned previously, informant discrepancies yield
meaningful information on the circumstances or contexts
within which children exhibit problematic behavior (De Los
Reyes and Kazdin 2006a, 2008, 2009; De Los Reyes et al.
2009a). In line with prior work, the findings suggest
consistency in informant discrepancies as observed within
controlled trials. This suggests that informant discrepancies
might be used as individual differences variables. Examin-
ing individual differences in informant discrepancies may
lead to a better understanding of children’s treatment
responsiveness. Indeed, informant discrepancies do not
necessarily imply that one or both of the informants’
reports are unreliable or that treatment was ineffective.
Consistencies in informant discrepancies over the course of
treatment might point to circumstances within which
children experience improvement versus those within
which concerns remain. Using traditional methods such as
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clinical ratings of improvement (e.g., CGI; Guy 1976), it
may be that informants often have to agree that the child’s
functioning improved in order for an independent evaluator
to identify the child as a treatment responder. Thus, when
informant discrepancies are consistently observed over the
course of treatment, traditional methods may not be
sensitive enough to identify how or under which circum-
stances improvement occurred. Alternatively, consistent
informant discrepancies over the course of treatment may
indicate that children simply have not responded to
treatment. These issues are worthy of empirical study to
establish whether consistently observed informant discrep-
ancies suggest a failure in treatment response or positive
responses observed under some circumstances and not others.
Our findings also have important implications for
clinical practice. Indeed, practitioners often observe the
same kinds of informant discrepancies in non-laboratory
based settings (e.g., Hawley and Weisz 2003). In fact, it is
highly likely that when a practitioner administers similar
measures to more than one informant during an intake,
informant discrepancies will arise. Our findings suggest that
clinicians have an opportunity to use these discrepancies to
guide assessment and treatment. Specifically, after intake,
each informant might be asked (independently) where they
typically observe the child’s problematic behaviors. At the
end of treatment, if informants disagree about treatment
effectiveness, a clinician could query specifically regarding
the situations where problems evident before treatment no
longer exist, as well as the situations where behavioral
problems still exist. Based on this information, discrep-
ancies could generate hypotheses about variable outcomes,
and guide clinicians to modify treatment plans to address
outstanding concerns. In sum, we encourage researchers
and practitioners to use informant discrepancies to guide
hypothesis generation and testing to understand children’s
responses to treatment and variability in these responses.
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